Document is current
Any future updates will be listed below
-
Authors
Hafner, Michael
Priglinger, Siegfried G.
von Livonius, Bettina
Gerhardt, Maximilian J.
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 28 May 2025
First Online: 20 June 2025
Declarations
:
: No author reports any financial interests related to this study. However, S.G.P. has received previous speaker fees and/or advisory board honoraria from Novartis Pharma GmbH, Pharm Allergan, Carl Zeiss Meditec AG, BVI, Bayer AG, Alcon Pharma GmbH, Bausch & Lomb (B&L), and Roche AG. S.G.P. also received consulting fees from Roche AG, Carl Zeiss Meditec AG, BVI, and B&L. M.J.G. received speaker fees and/or advisory board honoraria from Bayer, Janssen, Novartis, Rhythm Pharmaceuticals and Roche. He is consultant for ViGeneron, with all fees paid to LMU Eye Hospital to support research. M.H. and B.L. declare no financial disclosures. All authors confirm that there are no conflicts of interest regarding this manuscript.
